| A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate L Sanchez-Felipe, T Vercruysse, S Sharma, J Ma, V Lemmens, ... Nature 590 (7845), 320-325, 2021 | 172 | 2021 |
| Resurgence of chikungunya virus in India: an emerging threat SK Saxena, M Singh, N Mishra, V Lakshmi Euro Surveill 11 (8), E060810, 2006 | 101 | 2006 |
| Trend of Japanese encephalitis in North India: evidence from thirty-eight acute encephalitis cases and appraisal of niceties SK Saxena, N Mishra, R Saxena, M Singh, A Mathur The Journal of Infection in Developing Countries 3 (07), 517-530, 2009 | 87 | 2009 |
| A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice DB Kum, N Mishra, R Boudewijns, I Gladwyn-Ng, C Alfano, J Ma, ... npj Vaccines 3 (1), 56, 2018 | 44 | 2018 |
| A rat model for hepatitis E virus Y Debing, N Mishra, E Verbeken, K Ramaekers, K Dallmeier, J Neyts Disease models & mechanisms 9 (10), 1203-1210, 2016 | 39 | 2016 |
| Identification and characterisation of monoclonal antibodies that impair the activation of human thrombin activatable fibrinolysis inhibitor through different mechanisms N Mishra, E Vercauteren, J Develter, R Bammens, PJ Declerck, A Gils Thrombosis and haemostasis 106 (07), 90-101, 2011 | 35 | 2011 |
| Disease situation of some major fruit crops in new alluvial plains of West Bengal. DP Awasthi, S Sarkar, NK Mishra, S Kaiser | 35 | 2005 |
| A chimeric Japanese encephalitis vaccine protects against lethal yellow fever virus infection without inducing neutralizing antibodies N Mishra, R Boudewijns, MA Schmid, RE Marques, S Sharma, J Neyts, ... MBio 11 (2), 10.1128/mbio. 02494-19, 2020 | 28 | 2020 |
| A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice DB Kum, R Boudewijns, J Ma, N Mishra, D Schols, J Neyts, K Dallmeier Emerging microbes & infections 9 (1), 520-533, 2020 | 22 | 2020 |
| Advances in antiviral drug discovery and development: Part I: Advancements in antiviral drug discovery SK Saxena, N Mishra, R Saxena Future Medicine 4 (2), 101-107, 2009 | 20 | 2009 |
| Limited evolution of the yellow fever virus 17d in a mouse infection model DB Kum, N Mishra, B Vrancken, HJ Thibaut, A Wilder-Smith, P Lemey, ... Emerging microbes & infections 8 (1), 1734-1746, 2019 | 19 | 2019 |
| Genetic variability and character association in cashew. PC Lenka, KC Mohapatra, S Dash, NK Mishra | 18 | 2001 |
| Structural and antigenic variance between novel influenza A/H1N1/2009 and influenza A/H1N1/2008 viruses SK Saxena, N Mishra, R Saxena, MLA Swamy, P Sahgal, S Saxena, ... The Journal of Infection in Developing Countries 4 (01), 001-006, 2010 | 17 | 2010 |
| Increased zymogen activity of thrombin‐activatable fibrinolysis inhibitor prolongs clot lysis N Mishra, K Buelens, S Theyskens, G Compernolle, A Gils, PJ Declerck Journal of Thrombosis and Haemostasis 10 (6), 1091-1099, 2012 | 14 | 2012 |
| Swine flu: influenza A/H1N1 2009: the unseen and unsaid SK Saxena, N Mishra, R Saxena, S Saxena Future Microbiology 4 (8), 945-947, 2009 | 14 | 2009 |
| Studies on apple characterisation of cashew types and their physico-chemical characters. PC Lenka, KC Mohapatra, NK Mishra, S Dash | 13 | 1998 |
| A high-throughput yellow fever neutralization assay M Rasulova, T Vercruysse, J Paulissen, C Coun, V Suin, L Heyndrickx, ... Microbiology Spectrum 10 (3), e02548-21, 2022 | 12 | 2022 |
| Effect of nitrogen and phosphorus on flower production in marigold. CR Mohanty, NK Mishra, PP Padmaja Patnaik | 12 | 2002 |
| Emerging influenza A/H1N1: Challenges and development N Mishra theHealth 2 (1), 16-22, 2011 | 11 | 2011 |
| Advances in antiviral drug discovery and development: Part II: Advancements in antiviral drug development SK Saxena, N Mishra, R Saxena Future Virology 4 (3), 209-215, 2009 | 11 | 2009 |
